Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer

Published:2016-06-17 Issue:6 Volume:11 Page:e0157830
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Veluchamy John Pradeep^ORCID,Spanholtz Jan,Tordoir Marleen,Thijssen Victor L.,Heideman Daniëlle A. M.,Verheul Henk M. W.,de Gruijl Tanja D.,van der Vliet Hans J.

Funder

Marie Curie FP7 NATURIMMUN NETWORK

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS;MD Vincent;Curr Oncol,2012

2. EGFR and cancer prognosis;RI Nicholson;European Journal of Cancer,2001

3. Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment;J Capdevila;Cancer Treatment Reviews,2009

4. Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti–Epidermal Growth Factor Receptor Antibody Therapies;S Benvenuti;Cancer Research,2007

5. Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer;J-Y Douillard;New England Journal of Medicine,2013

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary Approaches to Immunotherapy of Solid Tumors;Cancers;2024-06-19

2. MHC1/LILRB1 axis as an innate immune checkpoint for cancer therapy;Frontiers in Immunology;2024-06-07

3. Transforming cancer care: Immunotherapy with advanced drug delivery;Journal of Drug Delivery Science and Technology;2024-06

4. Efficacy of nimotuzumab in combination with immunotherapy for a young recurrent cervical cancer patient: a case report and literature review;Anti-Cancer Drugs;2024-05-20

5. Memory-like differentiation enhances NK cell responses against colorectal cancer;OncoImmunology;2024-05-07